Ginkgo Bioworks
Ginkgo Bioworks is a synthetic biology and biotechnology company using machine learning techniques and lab automation to engineer microorganisms as a service.
All edits by James Smith
Edits on 19 Apr, 2018
James Smith
Edits made to:
Article (+3 characters)
Article
Ginkgo Bioworks had pre-money evaluation of $350 million before receiving $100 million in its series C funding round on June 8th, 2016. The funding came from a number of old and new investors including: Y Combinator, Viking Global Investors, Senator Investment Group, Baillie Gifford, and Allen & Company, and Allen & Company. .
Find more companies like Ginkgo Bioworks
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.